HomeNewscoronavirusCOVID-19 update | Offices allowed to open after disinfection; here are the guidelines

COVID-19 update | Offices allowed to open after disinfection; here are the guidelines

The health ministry said all individuals must maintain a minimum distance of 6 feet in common places as far as feasible in shared spaces like workstations, corridors, elevators and stairs, parking places, cafeteria/canteens, meeting rooms and conference halls etc.

February 15, 2021 / 07:23 IST
Story continues below Advertisement
Offices in containment zones will remain closed except for medical and essential services. (Source: Reuters)
Offices in containment zones will remain closed except for medical and essential services. (Source: Reuters)

The Union Ministry of Health and Family Welfare on February 14 allowed offices to open after disinfection, and issued standard operating procedure (SOP) to contain spread of COVID-19.

The ministry said offices and other workplaces are relatively close settings, with shared spaces like workstations, corridors, elevators and stairs, parking places, cafeteria/canteens, meeting rooms and conference
halls etc.

Story continues below Advertisement

It added that COVID-19 infection can spread relatively fast among officials, staffs and visitors in these spaces.

COVID-19 update | Centre issues fresh SOPs, allows offices to resume work after disinfection

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show